COVID Booster Shots This Fall Target New XBB.1.5 Variant

The current COVID vaccines will be replaced with a new formula targeting the XBB.1.5 variant, the dominant strain circulating in the U.S
The FDA advisory panel voted unanimously for the change to a monovalent vaccine focused solely on XBB.1.5
Vaccine makers Pfizer, Moderna and Novavax have doses ready and the new shots could be available in September
The CDC will decide who should receive the updated boosters and how often
There is uncertainty over whether the shots will need to be updated regularly or seasonally like the flu vaccine